Cargando…

Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo

PURPOSE: Multidrug resistance (MDR) remains a major obstacle in the treatment of triple-negative breast cancer (TNBC) with conventional chemotherapeutic agents. A previous study demonstrated that hsa-miRNA-143-3p plays a vital role in drug resistance of TNBC. Downregulation of hsa-miRNA-143-3p upreg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yu Wei, Hao, Wen Jing, Li, Yi Wen, Li, Yi Xin, Zhao, Bo Chen, Lu, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158160/ https://www.ncbi.nlm.nih.gov/pubmed/30275853 http://dx.doi.org/10.4048/jbc.2018.21.e40

Ejemplares similares

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

Circular RNA hsa_circ_0131242 Promotes Triple-Negative Breast Cancer Progression by Sponging hsa-miR-2682
por: Li, Yueting, et al.
Publicado: (2020)

miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL
por: Liang, Bing, et al.
Publicado: (2016)

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1
por: Dong, Li-Ming, et al.
Publicado: (2021)

Upregulation of microRNA-143 reverses drug resistance in human breast cancer cells via inhibition of cytokine-induced apoptosis inhibitor 1
por: Wang, Jing-Hao, et al.
Publicado: (2017)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Diagnostic value of elevated serum miRNA-143 levels in sepsis
por: Han, Yu, et al.
Publicado: (2016)

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
por: Shi, Zhendong, et al.
Publicado: (2017)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

Hsa_circ_0001925 promotes malignant progression in triple‐negative breast cancer via miR‐1299/YY1 axis
por: Shen, Bin‐jie, et al.
Publicado: (2023)

Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1
por: Song, Li-na, et al.
Publicado: (2020)

Lessons from miR-143/145: the importance of cell-type localization of miRNAs
por: Kent, Oliver A., et al.
Publicado: (2014)

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
por: Shu, Dan, et al.
Publicado: (2015)

Study of miR-143 expression in stomach cancer
por: Huang, Shao-Jun, et al.
Publicado: (2018)

Circular RNA hsa_circ_0000523 regulates the proliferation and apoptosis of colorectal cancer cells as miRNA sponge
por: Jin, Y., et al.
Publicado: (2018)

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo
por: La Rocca, Gaspare, et al.
Publicado: (2021)

[Retracted] Study of miR-143 expression in stomach cancer
por: Huang, Shao-Jun, et al.
Publicado: (2023)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
por: Ferreira, Lívia C., et al.
Publicado: (2020)

MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis
por: Liu, Yanli, et al.
Publicado: (2017)

Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression
por: Wu, Xuerui, et al.
Publicado: (2022)

Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma
por: Chen, Gaoyang, et al.
Publicado: (2018)

The Improvement of Porcine In Vitro Embryo Development through Regulating Autophagy by miRNA-143 Inhibition
por: Ridlo, Muhammad Rosyid, et al.
Publicado: (2022)

Hsa-miR-143-3p inhibits Wnt-β-catenin and MAPK signaling in human corneal epithelial stem cells
por: Kalaimani, Lavanya, et al.
Publicado: (2022)

Hsa-Let-7g miRNA Targets Caspase-3 and Inhibits the Apoptosis Induced by ox-LDL in Endothelial Cells
por: Zhang, Yefei, et al.
Publicado: (2013)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling
por: Li, Hongchang, et al.
Publicado: (2021)

MYC and hsa-miRNA-423-5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA-mRNA-pathway network integrated analysis
por: Tian, Huan, et al.
Publicado: (2017)

The mechanism of miR-143 inducing apoptosis of liver carcinoma cells through regulation of the NF-κB pathway
por: Zheng, Yi, et al.
Publicado: (2018)

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019)

Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma
por: Sanada, Hiroki, et al.
Publicado: (2019)

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake
por: Li, Zhen, et al.
Publicado: (2019)

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
por: Montag, Judith, et al.
Publicado: (2009)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Hsa_circ_0001982 promotes the proliferation, invasion, and multidrug resistance of osteosarcoma cells
por: Lin, Bochuan, et al.
Publicado: (2022)

Evaluation of miRNA-143 and miRNA-145 Expression and Their Association with Vitamin-D Status Among Obese and Non-Obese Type-2 Diabetic Patients
por: Aladel, Alanoud, et al.
Publicado: (2022)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_12oef4fp698g6r0plfuv8hmh2u